Cargando…
Use of Antiangiogenic Therapies in Pediatric Solid Tumors
SIMPLE SUMMARY: Cancer is one of the leading causes of death in children worldwide. One of the basic mechanisms for cancer development, both in children and in adults, is angiogenesis. This made it an important target for the development of antitumor drugs. Unfortunately, the clinical benefits of dr...
Autores principales: | Ollauri-Ibáñez, Claudia, Astigarraga, Itziar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827326/ https://www.ncbi.nlm.nih.gov/pubmed/33445470 http://dx.doi.org/10.3390/cancers13020253 |
Ejemplares similares
-
Hot and Cold Tumors: Is Endoglin (CD105) a Potential Target for Vessel Normalization?
por: Ollauri-Ibáñez, Claudia, et al.
Publicado: (2021) -
Splicing-Disrupting Mutations in Inherited Predisposition to Solid Pediatric Cancer
por: Alba-Pavón, Piedad, et al.
Publicado: (2022) -
Antiangiogenic Therapy for Glioma
por: Cea, Valentina, et al.
Publicado: (2012) -
Antiangiogenic Cancer Therapy
por: Maxwell, P H, et al.
Publicado: (2009) -
Antiangiogenic Therapy and Mechanisms of Tumor Resistance in Malignant Glioma
por: Rahman, Ruman, et al.
Publicado: (2010)